InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Robert Lorne Hopfner, Director, is a corporate insider tracked by InsiderTape across 3 companies. The public record shows 9 open-market SEC Form 4 transactions: 9 purchases worth $20.1M and 0 sales worth $0, reported from Aug 2, 21 to Dec 19, 25. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 25 | EVMNEvommune, Inc. | BUY | 1.0K | $17.35 | $17K |
| Aug 1, 23 | INZYInozyme Pharma, Inc. | BUY | 714.3K | $4.80 | $3.4M |
| May 12, 23 | INZYInozyme Pharma, Inc. | BUY | 228.7K | $6.25 | $1.4M |
| May 11, 23 | INZYInozyme Pharma, Inc. | BUY | 219.2K | $6.48 | $1.4M |
| Mar 29, 23 | INZYInozyme Pharma, Inc. | BUY | 344.6K | $4.54 | $1.6M |
| Mar 28, 23 | INZYInozyme Pharma, Inc. | BUY | 156.8K | $4.16 | $652K |
| Mar 27, 23 | INZYInozyme Pharma, Inc. | BUY | 51.1K | $3.70 | $189K |
| Apr 19, 22 | INZYInozyme Pharma, Inc. | BUY | 1.07M | $3.69 | $3.9M |
| Aug 2, 21 | RLYBRallybio Corp | BUY | 576.9K | $13.00 | $7.5M |